CS208660B2 - Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives - Google Patents

Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives

Info

Publication number
CS208660B2
CS208660B2 CS794630A CS463079A CS208660B2 CS 208660 B2 CS208660 B2 CS 208660B2 CS 794630 A CS794630 A CS 794630A CS 463079 A CS463079 A CS 463079A CS 208660 B2 CS208660 B2 CS 208660B2
Authority
CS
Czechoslovakia
Prior art keywords
dimethyl
compounds
compound
hydroxyethyl
group
Prior art date
Application number
CS794630A
Other languages
Czech (cs)
English (en)
Inventor
Jack Mills
Klaus K Schmiegel
Richard E Toomey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS208660B2 publication Critical patent/CS208660B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS794630A 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives CS208660B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
CS208660B2 true CS208660B2 (en) 1981-09-15

Family

ID=25445786

Family Applications (2)

Application Number Title Priority Date Filing Date
CS794630A CS208661B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives
CS794630A CS208660B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS794630A CS208661B2 (en) 1978-07-03 1979-07-02 Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives

Country Status (33)

Country Link
EP (2) EP0007206B1 (de)
JP (1) JPS559100A (de)
AR (2) AR222658A1 (de)
AT (1) AT370408B (de)
AU (1) AU521744B2 (de)
BE (1) BE877392A (de)
BG (3) BG40480A3 (de)
CA (1) CA1120058A (de)
CH (1) CH641759A5 (de)
CS (2) CS208661B2 (de)
DD (1) DD144763A5 (de)
DK (1) DK268579A (de)
EG (1) EG14400A (de)
ES (2) ES482153A1 (de)
FI (1) FI67686C (de)
FR (1) FR2430409A1 (de)
GB (1) GB2028800B (de)
GR (1) GR72546B (de)
HK (1) HK44087A (de)
HU (1) HU179170B (de)
IE (1) IE48436B1 (de)
IL (1) IL57670A (de)
LU (1) LU81456A1 (de)
MX (1) MX6160E (de)
MY (1) MY8500596A (de)
NZ (1) NZ190859A (de)
PH (1) PH15650A (de)
PL (2) PL119783B1 (de)
PT (1) PT69840A (de)
RO (2) RO83053B (de)
SU (2) SU965351A3 (de)
YU (1) YU154879A (de)
ZA (1) ZA793295B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (de) * 1981-06-20 1983-01-05 Beecham Group Plc Sekundäre Phenyläthanolamine, Verfahren zu deren Herstellung und deren pharmazeutische Verwendung
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (de) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolaminderivate, sie enthaltende pharmazeutische Mittel sowie Verfahren zu ihrer Herstellung
GR79758B (de) * 1983-01-31 1984-10-31 Lilly Co Eli
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (de) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
EP0047536A2 (de) 1982-03-17
PL119783B1 (en) 1982-01-30
YU154879A (en) 1983-04-30
EP0047536A3 (en) 1982-03-24
ES487847A0 (es) 1980-12-16
LU81456A1 (fr) 1979-10-30
IL57670A0 (en) 1979-10-31
IE48436B1 (en) 1985-01-23
GB2028800A (en) 1980-03-12
MY8500596A (en) 1985-12-31
EP0007206B1 (de) 1983-02-23
HU179170B (en) 1982-08-28
PH15650A (en) 1983-03-11
MX6160E (es) 1984-11-29
AU4848879A (en) 1980-01-10
FI67686B (fi) 1985-01-31
RO83053A (ro) 1984-02-21
AU521744B2 (en) 1982-04-29
AR222658A1 (es) 1981-06-15
BG40481A3 (en) 1986-12-15
GB2028800B (en) 1982-11-03
JPS636058B2 (de) 1988-02-08
CS208661B2 (en) 1981-09-15
AT370408B (de) 1983-03-25
JPS559100A (en) 1980-01-22
BE877392A (fr) 1980-01-02
PL123990B1 (en) 1982-12-31
EG14400A (en) 1983-12-31
GR72546B (de) 1983-11-17
ZA793295B (en) 1981-02-25
PL216810A1 (de) 1980-07-28
PT69840A (en) 1979-07-01
IE791231L (en) 1980-01-03
RO83053B (ro) 1984-02-28
DD144763A5 (de) 1980-11-05
ES482153A1 (es) 1980-08-16
HK44087A (en) 1987-06-12
CA1120058A (en) 1982-03-16
DK268579A (da) 1980-01-04
EP0047536B1 (de) 1984-06-27
FR2430409A1 (fr) 1980-02-01
FR2430409B1 (de) 1981-05-29
FI67686C (fi) 1985-05-10
RO77731A (ro) 1981-11-24
ES8101537A1 (es) 1980-12-16
SU965351A3 (ru) 1982-10-07
BG40480A3 (en) 1986-12-15
BG40482A3 (en) 1986-12-15
ATA463979A (de) 1982-08-15
AR222727A1 (es) 1981-06-15
IL57670A (en) 1982-11-30
EP0007206A1 (de) 1980-01-23
CH641759A5 (fr) 1984-03-15
PL222867A1 (de) 1981-01-02
NZ190859A (en) 1984-09-28
SU931102A3 (ru) 1982-05-23
FI792080A (fi) 1980-01-04

Similar Documents

Publication Publication Date Title
CS208660B2 (en) Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives
US20160068466A1 (en) Ester derivatives of androgen receptor modulators and methods for their use
CS227019B2 (en) Method of preparing (-)-n-methyl-3-(2-methylphenyloxy)-3-phenylpropylamine
AU2021215274B2 (en) Targeted drug rescue with novel compositions, combinations, and methods thereof
HU189166B (en) Process for producing pyridazin-amine derivatives
CS239929B2 (en) Processing of pyridazine derivatives
US20200069674A1 (en) Targeted drug rescue with novel compositions, combinations, and methods thereof
NZ726348A (en) Androgen receptor modulators and methods for their use
CH662563A5 (fr) Derives de coumarine, leurs procedes de preparation et compositions pharmaceutiques les contenant.
US7005539B2 (en) Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
EP0063084A1 (de) Phenethanolamin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CZ321095A3 (en) Heterocyclic compounds
FR2559771A1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
KR820001304B1 (ko) 펜아탄올아민의 제조방법
US4307091A (en) Process for treatment of allergic conditions with benzoxazinediones
JPH06511259A (ja) 治療用アミン
US4857529A (en) Interferon inducing, anti-vaccinia, and/or anti-influenza compositions
CN112714761A (zh) 用作分子伴侣介导的自噬调节剂的化合物
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
CS208752B2 (en) Method of making the r-n-(2-fenyl-2-hydroxyethyl)-3-fenyl propylamines
JP3681770B2 (ja) 老年性痴呆症又はアルツハイマー病治療剤
KR800000262B1 (ko) 3-아미노-2-하이드록시프로판의 디치환 페놀 에텔 유도체의 제조방법
KR800000251B1 (ko) 3-아미노-2-하이드록시 프로판의 디치환 페놀 에텔 유도체의 제조방법
JPS63208519A (ja) 発癌促進物質抑制剤
CH629194A5 (fr) Amino aryl triazines-1,2,4 utilisables dans le traitement d'algies diverses.